“Anti-NMDA receptor encephalitis” was the name given to an acute brain disease, whose potential cause and treatment has been described in a number of recent publications. On the molecular level, this acute form of encephalitis is attended by a reduced function of glutamate receptors (NMDAR), which is caused by autoantibodies against these receptors in the brain.
Symptoms of the disease can be psychosis, movement disorders, epileptic seizures or reduction of cognitive performance in various shapes. However, as most studies are based on a generally fairly small number of patients, they neither cast a light on the relevance of NMDAR autoantibodies in the blood for the pathogenesis of the disease, nor do they yield data about their prevalence in healthy individuals.
Notable new findings are now provided by a new study conducted by Prof. Hannelore Ehrenreich and her team in cooperation with the Göttingen DFG Research Center and Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB).
The study demonstrates for the first time that NMDAR autoantibodies can be found in the serum of more than 10% of a total of nearly 3000 tested individuals, irrespective of whether they are patients or healthy individuals. Surprisingly, comparable autoantibody titers, antibody classes and functionalities were detected in healthy subjects and patients with a neuropsychiatric disease.
This insight led the authors of the study to the following central question: If, in fact, these autoantibodies play some pathological role, why do healthy individuals bearing them stay healthy?
In a series of animal experiments the scientists could demonstrate that the prerequisite for a triggering of symptoms by these autoantibodies, and thus for the pathogenesis of a disease process, is a dysfunction of the blood-brain barrier. This physiological barrier in a healthy organism delimits the central nervous system like a filter from the general blood stream and thus protects it from circulating pathogenic agents and toxins. A disruption of its natural barrier function enables the NMDAR autoantibodies circulating in the blood to enter the brain. This way, they reach the NMDA receptors located in the brain and can cause an impairment of function resulting in psychosis-similar symptoms, epileptic seizures or cognitive dysfunctions.
"In other words, more than 10% of all individuals carry a 'ticking time bomb', the disease relevance of which is only suppressed by an intact blood-brain barrier“, remarks Prof. Ehrenreich. An impaired blood brain barrier can be caused by a stroke, a brain trauma or by a viral infection, amongst others. In this context, the scientists performed an additional retrospective evaluation based on a large cohort of patients. They demonstrate an increase in the severity of neurological symptoms in subjects with a temporary or persisting blood-brain barrier dysfunction who carry NMDAR autoantibodies in their serum.
The authors of the study for the first time examined the question which factors are, in the end, responsible for triggering the generation of these NMDA autoantibodies. They found, on the one hand, an association of past influenza A or B infections with the appearance of these autoantibodies; on the other hand they identified by means of a genome-wide association study a genetic risk factor related to NMDAR biology.
The study published by first author Christian Hammer and coworkers is not only conceptually novel, it also yields considerable insight into a pathophysiological mechanism that is of crucial importance for neuropsychiatry and also for other clinical disciplines. The scientists commend that “patients with acute or chronic impairment of the blood-brain-barrier, e.g. after a brain injury, a stroke, any kind of encephalitis, epilepsy and also multiple sclerosis should be screened for the presence of NMDAR autoantibodies”. This might contribute to improve the course of disease by appropriate therapeutic methods and prevent long-term complications.
Dr. Heike Benecke | idw
Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex
New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center
In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.
Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
22.06.2018 | Materials Sciences
22.06.2018 | Earth Sciences
22.06.2018 | Life Sciences